PMDA — authorised 28 September 2016
- Marketing authorisation holder: MSD K.K.
- Status: approved
PMDA authorised Keytruda on 28 September 2016
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 28 September 2016.
MSD K.K. holds the Japanese marketing authorisation.